相关实验视频

Updated: Jul 20, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

在动脉样硬化心血管疾病风险评估中,Apolipoprotein B 与低密度脂蛋白胆固醇相比

Federica Galimberti¹, Manuela Casula², Elena Olmastroni³

¹IRCCS MultiMedica, Sesto S. Giovanni, MI, Italy.

Pharmacological research

|July 30, 2023

概括

阿波利波蛋白B (apoB) 水平,代表了有氧化物颗粒的总数,是心血管疾病风险的更好的指标,而不是单独的LDL胆固醇. 测量apoB和LDL胆固醇可以改善心血管风险评估,特别是在高风险患者中.

科学领域:

心血管医学心血管医学
脂质代谢脂质代谢是什么
生物化学生物化学

背景情况:

含有阿波利波蛋白B (apoB) 的脂蛋白在脑内膜下被保留,从而启动动动脉硬化过程.
颗粒数量,而不是脂质含量,是动脉生成的关键.
ApoB水平反映了有机脂蛋白 (LDL,IDL,VLDL) 的总计数.

研究的目的:

评估阿波利波蛋白B (apoB) 与LDL胆固醇相比,作为动脉样硬化心血管疾病 (ASCVD) 风险的优越标志物.
强调在特定患者子组中测量apoB的重要性.
强调对apoB和LDL胆固醇的常规测量,以进行全面的风险评估.

主要方法:

对基因和临床证据的审查,支持apoB在动脉动脉生成中的作用.
在评估心血管风险时,apoB水平与LDL胆固醇的比较.
分析apob在不同患者群体中的实用性,包括糖尿病患者和代谢综合征患者.

主要成果:

ApoB水平独立于粒子密度和胆固醇含量的异质性.
ApoB比LDL胆固醇更准确地预测ASCVD风险,特别是在特定的患者群体中.
定期测量APOB和LDL胆固醇对于准确的风险分层至关重要.

结论:

阿波利波蛋白B (apoB) 是比LDL胆固醇更可靠的动脉样硬化心血管疾病 (ASCVD) 风险标志物.
测量apoB和LDL胆固醇可以提高心血管风险评估和治疗有效性的监测.
这种方法对于治疗患者的残留ASCVD风险的管理至关重要.

关键词:

乙类阿波利波蛋白 (B) 是一种阿波利波蛋白.动脉样硬化心血管疾病的风险胆固醇含量胆固醇含量胆固醇含量低密度脂蛋白是一种低密度脂蛋白.颗粒数颗粒数颗粒数

更多相关视频

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Quantification of Atherosclerosis in Mice

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

相关概念视频

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...